Skip Menu Navigate: Select to Navigate... - Kayed Lab Home - Members - Publications - Open Positions - Contact Us Kayed Lab Home Members Publications Open Positions Contact Us Seminal PublicationsPuangmalai N, Bhatt N, Puangmalai N, Bhatt N, Montalbano M, Sengupta U, Gaikwad S, Ventura F, McAllen S, Ellsworth A, Garcia S, and Kayed R. Internalization mechanisms of brain-derived Tau oligomers from patients with Alzheimer’s disease, Progressive Supranuclear Palsy and Dementia with Lewy Bodies. Cell Death and Disease. 2020, 11 (5), 1-16. PMID: 32366836Mauro Montalbano, Salome McAllen, Nicha Puangmalai, Urmi Sengupta, Nemil Bhatt, Omar D. Johnson, Michael G. Kharas, Rakez Kayed. RNA-Binding Proteins Musashi and Tau soluble aggregates initiate nuclear dysfunction in tauopathies. Nature Comunications. 2020. Published.Gerson JE, Gerson JE, Farmer K, Henson N, Castillo-Carranza DL, Carretero-Murillo M, Sengupta U, Barrett A, Kayed R. Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy. 2018 Feb, Molecular Neurodegeneration. 2018 Mar 15;13(1):13. PMID: 29544548. PMCID: PMC5856311.Castillo-Carranza DL, Gerson JE, Sengupta U, M. J. Guerrero-Muñoz MJ, Lasagna-Reeves CA, Kayed R. (2014). Passive immunization with tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary. Journal of Neuroscience, Mar 19; 34(12):4260-72. PMID: 24647946.Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Munoz MJ, Jackson GR, Kayed R. (2010). Preparation and characterization of neurotoxic tau oligomers. Biochemistry, Nov 30; 49(47):10039-41. Rapid reports. PMID: 21047142.Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. (2011). Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Molecular Neurodegeneration, Jun 6; 6:39. PMCID: PMC3224595Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, Kayed R. (2012). Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J., 26 (5):1946-59. PMCID: PMC4046102Lasagna-Reeves, CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V, Jackson GR, Kayed R. (2012). Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Scientific Reports, Oct 3; 2:700. PMCID: PMC463004.Castillo-Carranza DL, Guerrero-Munoz MJ, Gerson J, Sengupta U, Kayed R. α-Synuclein oligomers induce a unique toxic tau strain. Biological Psychiatry. 2018 Jan 17. 2018 Oct 1;84(7):499-508.PMID: 29478699. Chosen for cover.Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, Apr 18; 300 (5618):486-9. PMID: 12702875